Back to Search
MARC HOCHBERG, M.D.
M.D.
Rheumatology Physician
NPI: 1992766794IndividualAccepts Medicare
Specialties, Licenses & Credentials
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
D0017972(MD)
Education
JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE
Class of 1973
Research & Publications (20)
The rate of decline of joint space width in patients with osteoarthritis of the knee: a systematic review and meta-analysis of randomized placebo-controlled trials of chondroitin sulfate .
PMID 18826751·Curr Med Res Opin·2008
1-meta
Screening for osteoporosis in men: comment on the American College of Physicians clinical guidelines.
PMID 18839012·Nat Clin Pract Rheumatol·2008
8-other
Potential effects of chondroitin sulfate on joint swelling: a GAIT report.
PMID 18768335·Osteoarthritis Cartilage·2008
4-observational
Nonvertebral fracture risk reduction with nitrogen-containing bisphosphonates.
PMID 18752769·Curr Osteoporos Rep·2008
6-review
The incidence and prevalence of extra-articular and systemic manifestations in a cohort of newly-diagnosed patients with rheumatoid arthritis between 1999 and 2006.
PMID 18179735·Curr Med Res Opin·2008
8-other
Recommendations for measurement of bone mineral density and identifying persons to be treated for osteoporosis.
PMID 17288971·Rheum Dis Clin North Am·2006
6-review
Long-term experience with alendronate in the treatment of osteoporosis.
PMID 16732706·Expert Opin Pharmacother·2006
6-review
Risk factors for the development and progression of hip osteoarthritis.
PMID 15977344·J Rheumatol·2005
6-review
COX-2 selective inhibitors in the treatment of arthritis: a rheumatologist perspective.
PMID 15974939·Curr Top Med Chem·2005
4-observational
The benefit/risk profile of TNF-blocking agents: findings of a consensus panel.
PMID 15942917·Semin Arthritis Rheum·2005
6-review
Effect of alendronate on the age-specific incidence of symptomatic osteoporotic fractures.
PMID 15883637·J Bone Miner Res·2005
3-trial
Bone mineral density and osteoarthritis: data from the Baltimore Longitudinal Study of Aging.
PMID 14698641·Osteoarthritis Cartilage·2004
8-other
Do risk factors for incident hip osteoarthritis (OA) differ from those for progression of hip OA?
PMID 15132348·J Rheumatol Suppl·2004
6-review
Comparison of the efficacy of the tumour necrosis factor alpha blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis.
PMID 14532140·Ann Rheum Dis·2003
4-observational
COX-2: Where are we in 2003? - Be strong and resolute: continue to use COX-2 selective inhibitors at recommended dosages in appropriate patients.
PMID 12716445·Arthritis Res Ther·2003
8-other
New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis.
PMID 12528069·Semin Arthritis Rheum·2002
6-review
Introduction. New directions in anti-inflammatory therapy and pain management.
PMID 12528068·Semin Arthritis Rheum·2002
6-review
Treatment of rheumatoid arthritis and osteoarthritis with COX-2-selective inhibitors: a managed care perspective.
PMID 12458820·Am J Manag Care·2002
4-observational
Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents.
PMID 11932287·J Clin Endocrinol Metab·2002
1-meta
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 22 S GREENE ST
BALTIMORE, MD 21201 - Phone
- (410) 706-6474
Quick Facts
- NPI
- 1992766794
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 53
- Publications
- 20
Are you this provider?
Claim Your Profile